Viatris (VTRS) Change in Account Payables (2020 - 2026)

Viatris' (VTRS) quarterly Change in Account Payables came in at $32.7 million in Q1 2026, down 67.81% year-on-year from $101.6 million in Q1 2025, and up 76.76% quarter-over-quarter from $18.5 million in Q4 2025.

Viatris (VTRS) Change in Account Payables (2020 - 2026) Analysis & Trends

Viatris' Change in Account Payables history runs 7 years deep, the most recent figure standing at $32.7 million for Q1 2026.

  • On a quarterly basis, Change in Account Payables fell 67.81% year-over-year to $32.7 million in Q1 2026; TTM through Mar 2026 was -$236.9 million, a 57.62% decrease from a year earlier, with the FY2025 full-year figure at -$168.0 million, down 566.67% from the prior year.
  • Change in Account Payables grew to $32.7 million in Q1 2026 per VTRS's latest filing, from $18.5 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $287.9 million in Q1 2024 and bottomed at -$329.9 million in Q3 2022.
  • The 5-year median for Change in Account Payables is $32.7 million (2026), against an average of $22.7 million.
  • Across the five-year window, Change in Account Payables surged 707.28% in 2023 and slumped 2590.32% in 2024, its largest moves.
  • Year by year, Change in Account Payables stood at $245.6 million in 2022, then sank by 68.08% to $78.4 million in 2023, then tumbled by 41.71% to $45.7 million in 2024, then tumbled by 59.52% to $18.5 million in 2025, then soared by 76.76% to $32.7 million in 2026.
  • Per Business Quant, the three latest VTRS Change in Account Payables figures stand at $32.7 million (Q1 2026), $18.5 million (Q4 2025), and $3.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 30.60 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 32.70 Mn
Mar 31, 2026 32.70 Mn
Dec 31, 2025 18.50 Mn
Dec 31, 2025 18.50 Mn
Sep 30, 2025 3.20 Mn
Sep 30, 2025 3.20 Mn
Jun 30, 2025 -291.30 Mn
Jun 30, 2025 -291.30 Mn
Mar 31, 2025 101.60 Mn
Mar 31, 2025 101.60 Mn
Dec 31, 2024 45.70 Mn
Dec 31, 2024 45.70 Mn
Sep 30, 2024 -66.00 Mn
Sep 30, 2024 -66.00 Mn
Jun 30, 2024 -231.60 Mn
Jun 30, 2024 -231.60 Mn
Mar 31, 2024 287.90 Mn
Mar 31, 2024 287.90 Mn
Dec 31, 2023 78.40 Mn
Dec 31, 2023 78.40 Mn